🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What is hepatorenal syndrome? A #Livertwitter #tweetorial Hepatology is awesome, exciting, but also humbling. Nowhere is that clearer than HRS, a true unmet need for patients with ascites Aims 1. What 2. Why 3. How to prevent/treat 4. ❤️ #cirrhosis physiology

🚨🚨Happy to share our last paper!!!🚨🚨 Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort - Journal of Hepatology journal-of-hepatology.eu/article/S0168-…

Dr Hirschfield presenting exciting data on PBC management!

Do you have doubts on how to manage PSC? Please see our review of the state of the art management at hepcomm! doi.org/10.1097/HC9.00…

📢 Live from #TLM2024 A meta-analysis suggests that fibrates may be a better option than OCA for patients with PBC who do not respond to UDCA. AASLD Guilherme Grossi, MD, MSc, PhD Eliabe S. Abreu, M.D. ALEH

Happy to share our latest research on CFTR modulators and their impact on organ transplantation in CF patients ❌Liver Tx rates remained stable post-CFTR mod introduction ✅Lung tx dropped by 81%. ‼️More data needed to assess liver outcomes 🔒shorturl.at/ZU3al

In pts w #hepaticencephalopathy on max Rx..how can we⬇️recurrence? #gutbrainaxis In our #FMT Phase 2 trial Journal of Hepatology funded by VA Research 🔑FMT capsule💊/💉enema➡️safe 🔑 FMT doses (1-2-3) >>placebo ⬇️HE recurrence 🔑 Donor engraftment matters!⤵️ pubmed.ncbi.nlm.nih.gov/39800192/

Acute pancreatitis: an update of evidence-based management 🆕 🆓: UEGJ 📸: onlinelibrary.wiley.com/doi/10.1002/ue…

Review Liver transplantation for cholestatic liver diseases: Timing & disease recurrence Cançado et al. #LiverX tinyurl.com/retpd49a

Articulo de Revisión Trasplante hepático para enfermedades hepáticas colestásicas: Momento y recurrencia de la enfermedad Cançado et al. #LiverX tinyurl.com/retpd49a

Original Article Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study Moeckli et al. #LiverX tinyurl.com/yrt77t4k

link.springer.com/article/10.100… Check out our meta-analysis on a hot topic in PBC treatment — brilliantly led by Eliabe S. Abreu, M.D.

Under the great mentorship of Guilherme Grossi, MD, MSc, PhD Check it out! Special thanks to Meta Analysis Academy - a game changing training in science!

The Arts and science of Psc and Autoimmune hepatitis with the one and only Gideon Hirschfield🇬🇧🇨🇦 We talk #diagnosis #treatment #UC #psc #UDCA #ourbiggestfan And much more… you don’t wanna miss this one podcasts.apple.com/gb/podcast/two…

Glad to have presented three posters at #DDW2025, two of them addressing therapeutics for patients with Primary Biliary Cholangitis under the mentorship of Guilherme Grossi, MD, MSc, PhD. Can’t wait for the next opportunity at #TLM2025 - see you at Washington D.C.

No se pierdan el Webinar ALEH + Asociación Española para el Estudio del Hígado el 📅 Jueves 15 mayo 2025. Tenemos 2 grandes speakers Sebastian Marciano y Juan Turnes que entregarán estrategias para escribir abstracts (incluyendo IA 🤖). Inscripciones ✅: eventual-latam.us12.list-manage.com/track/click?u=… AASLD EASL Education #LiverTwitter

Imperdible! ALEH Sebastian Marciano Juan Turnes

Happy mother’s day!

Excited to share our new manuscript on a risk-stratified approach to PBC, now published in The Lancet Gastroenterology & Hepatology Many thanks to Dr. Hirschfield for the incredible mentorship throughout this project! Treat wisely! Treat to targets! #livertwitter thelancet.com/journals/langa…

Focal liver lesions: summary of the 2024 ACG guidelines 🆕💡 #4KMedEd